About FormBlends Guides
What this site is, who writes it, how each guide is sourced, what it will never tell you, and how to reach the editorial team.
FormBlends Guides is the how-to library of the FormBlends network: long-form, sourced answers to the practical questions that come up once a GLP-1 prescription is in the fridge and the instructions for use have been read twice.
What the site is
Twenty guides in four groups. Injecting covers technique for each labelled site, rotation, pens versus vials and syringes, storage, temperature excursions and travel. Daily life covers alcohol, surgery and anaesthesia, nausea, hydration and constipation, hair shedding, muscle and the weeks when a dose step is not going well. Planning covers pregnancy, switching between agents, stopping and maintenance, insurance appeals and how to prepare for a prescriber visit. Reference holds the glossary. One tool sits alongside them: an injection site rotation planner that lays out where to inject for the next 8 to 16 weeks and prints on one page. It has no dose logic at all.
Who runs it
The FormBlends editorial team writes and maintains the site. The same team publishes formblends.com, which operates a GLP-1 weight-loss program dispensing compounded semaglutide and tirzepatide through licensed pharmacies. That is a commercial interest, and it is disclosed here, in the medical disclaimer, and on every page that links to a FormBlends product. Compounded drugs are not FDA approved and are not interchangeable with Zepbound, Mounjaro, Wegovy or Ozempic; the guides say so wherever the distinction matters, and they cite the brand labels because those are the only labels that exist.
Contact: hello@formblends.com. Corrections get priority. If you send one, quote the sentence and the source you believe contradicts it.
How a guide is sourced
Every clinical statement traces to one of three places: the current FDA prescribing information and instructions for use for Zepbound, Mounjaro, Wegovy or Ozempic on DailyMed; an FDA safety communication or press announcement with its date; or a peer-reviewed publication identified by PubMed id. The label is always the first stop, because it is the only document that has been reviewed by the FDA and because it changes. Where a guide quotes a label rule (a missed-dose window, a storage limit, a wash-out period) it names the product, because the rules differ between products more often than people expect.
Practical detail that goes beyond the label, such as how far apart to space injections or how to manage constipation, is framed as general practice and attributed to the body that published it: the Forum for Injection Technique recommendations, a gastroenterology society guideline, an anaesthesiology society statement, or a multidisciplinary consensus paper. If we could not find a source we were willing to cite, the sentence was cut. Several guides contain a section headed "What the label does not say" for exactly that reason.
Sources appear in two places: inline, where the number or rule is used, and in the source list at the end of every page with the date we last checked it.
What the guides will never do
They will not tell you what dose to take, when to move up a step, or whether to stop. They will not name a clinician who "reviewed" a page, because none did, and they will not carry testimonials, star ratings or patient stories, invented or otherwise. They do not track you across the network, and the rotation planner runs entirely in your browser; the dates you enter never leave it.
Editorial process
A guide is drafted from the label first, then the trials and guidance are added, then every number is checked against its source a second time by a different member of the team. A guide is re-read whenever one of the four labels is revised on DailyMed, and the updated date on the page changes only when the content changed, not when we merely re-checked it. The em dash is banned from the house style, as is the phrase "it's important to note".
The rest of the network
Sibling sites do neighbouring jobs. FormBlends Calculators does the dosing arithmetic these guides refuse to do. FormBlends Tools and Templates has the printable logs and letters. Weight Loss on GLP-1s goes deeper on nutrition and training. GLP-1 Pricing Index carries the price and coverage data behind the insurance guide here. The FormBlends tirzepatide introduction is the main-site starting point for that drug.
Medical disclaimer, short form
Everything here is educational. It is not medical advice, it does not create a clinician relationship, and it does not replace the instructions for use in your box or the person who prescribed it. If a guide and your prescriber disagree, your prescriber wins. In an emergency call your local emergency number.
Sources
- FormBlends Accessed September 4, 2026.
- DailyMed, U.S. National Library of Medicine (source of every FDA label cited on this site) Accessed September 4, 2026.
- FDA: Human Drug Compounding Accessed September 4, 2026.